For research use only. Not for therapeutic Use.
Deruxtecan 2-hydroxypropanamide is a highly stable Deruxtecan (HY-13631E) analog that specifically binds to receptors highly expressed in tumor cells[1].
| Catalog Number | I040077 |
| CAS Number | 2577204-16-9 |
| Synonyms | (2S)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-2-hydroxypropanamide |
| Molecular Formula | C27H26FN3O6 |
| Purity | ≥95% |
| InChI | InChI=1S/C27H26FN3O6/c1-4-27(36)16-7-20-23-14(9-31(20)25(34)15(16)10-37-26(27)35)22-18(30-24(33)12(3)32)6-5-13-11(2)17(28)8-19(29-23)21(13)22/h7-8,12,18,32,36H,4-6,9-10H2,1-3H3,(H,30,33)/t12-,18-,27-/m0/s1 |
| InChIKey | UOCFLIUBXYLYLD-BEMWVBDCSA-N |
| SMILES | CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)C(C)O)O |
| Reference | [1]. Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof. World Intellectual Property Organization, et al. World Intellectual Property Organization, WO2021249228 A1 2021-12-16. |
